IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-3-319-09075-7_2.html
   My bibliography  Save this book chapter

Clinical Aspects of Pharmaceutical Portfolio Management

In: Optimization of Pharmaceutical R&D Programs and Portfolios

Author

Listed:
  • Frederic (Rick) Sax

    (Quintiles Transnational Corp.)

  • Raymond A. Huml

    (Quintiles Transnational Corp.)

  • Judith Ng-Cashin

    (Quintiles Transnational Corp.)

Abstract

This chapter examines the clinical aspects of pharmaceutical portfolio decision-making – a key driver of shareholder value – from the perspective of an Executive Committee reporting on portfolio strategy to a Board of Directors. Areas that are particularly important for shareholder value include a thorough evaluation of manufacturing and clinical drug development costs, commercial expectations, and the clinical risk/benefit assessment for each product. Other ways to evaluate risks associated with portfolio management include competitive intelligence, due diligence, patent protection and regulatory exclusivity. Portfolio managers must be aware of biases that can be inherent in portfolio decision-making, balancing those factors that may artificially increase or decrease the estimated probability of registration or commercial success. Complex tools, such as including adaptive design principles, and large data software tools can also be utilized to minimize and mitigate the risk and bias embraced by both the R&D and commercial factors

Suggested Citation

  • Frederic (Rick) Sax & Raymond A. Huml & Judith Ng-Cashin, 2015. "Clinical Aspects of Pharmaceutical Portfolio Management," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, chapter 0, pages 19-33, Springer.
    • Handle: RePEc:spr:sprchp:978-3-319-09075-7_2
    DOI: 10.1007/978-3-319-09075-7_2
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-3-319-09075-7_2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.